MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT

KORIOTH F, GIEFFERS C, MAUL GG, FREY J (1995)
JOURNAL OF CELL BIOLOGY 130(1): 1-13.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

KORIOTH F, GIEFFERS C, MAUL GG, FREY J. MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT. JOURNAL OF CELL BIOLOGY. 1995;130(1):1-13.
KORIOTH, F., GIEFFERS, C., MAUL, G. G., & FREY, J. (1995). MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT. JOURNAL OF CELL BIOLOGY, 130(1), 1-13. doi:10.1083/jcb.130.1.1
KORIOTH, F., GIEFFERS, C., MAUL, G. G., and FREY, J. (1995). MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT. JOURNAL OF CELL BIOLOGY 130, 1-13.
KORIOTH, F., et al., 1995. MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT. JOURNAL OF CELL BIOLOGY, 130(1), p 1-13.
F. KORIOTH, et al., “MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT”, JOURNAL OF CELL BIOLOGY, vol. 130, 1995, pp. 1-13.
KORIOTH, F., GIEFFERS, C., MAUL, G.G., FREY, J.: MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT. JOURNAL OF CELL BIOLOGY. 130, 1-13 (1995).
KORIOTH, F, GIEFFERS, C, MAUL, GG, and FREY, J. “MOLECULAR CHARACTERIZATION OF NDP52, A NOVEL PROTEIN OF THE NUCLEAR DOMAIN-10, WHICH IS REDISTRIBUTED UPON VIRUS-INFECTION AND INTERFERON TREATMENT”. JOURNAL OF CELL BIOLOGY 130.1 (1995): 1-13.
This data publication is cited in the following publications:
This publication cites the following data publications:

64 Citations in Europe PMC

Data provided by Europe PubMed Central.

Nuclear scaffold proteins are differently sensitive to stabilizing treatment by heat or Cu++.
Neri LM, Riederer BM, Marugg RA, Capitani S, Martelli AM., J Histochem Cytochem 45(2), 1997
PMID: 9016318
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.
Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z, de Thé H., Proc Natl Acad Sci U S A 94(8), 1997
PMID: 9108090
A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots.
Grötzinger T, Jensen K, Guldner HH, Sternsdorf T, Szostecki C, Schwab M, Savelyeva L, Reich B, Will H., Mol Cell Biol 16(3), 1996
PMID: 8622659
The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.
Szekely L, Pokrovskaja K, Jiang WQ, de The H, Ringertz N, Klein G., J Virol 70(4), 1996
PMID: 8642686
Temporal expression of types XII and XIV collagen mRNA and protein during avian corneal development.
Gordon MK, Foley JW, Lisenmayer TF, Fitch JM., Dev Dyn 206(1), 1996
PMID: 9019246
The RING finger domain: a recent example of a sequence-structure family.
Borden KL, Freemont PS., Curr Opin Struct Biol 6(3), 1996
PMID: 8804826
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition.
Ishov AM, Maul GG., J Cell Biol 134(4), 1996
PMID: 8769408
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B, Pacini R, Tanci LN, Pasqualucci L, Ascani S, Mencarelli A, Liso A, Pelicci PG, Falini B., Am J Pathol 149(6), 1996
PMID: 8952536
The PML nuclear compartment and cancer.
Doucas V, Evans RM., Biochim Biophys Acta 1288(3), 1996
PMID: 9011178
Single-headed myosin II acts as a dominant negative mutation in Dictyostelium.
Burns CG, Larochelle DA, Erickson H, Reedy M, De Lozanne A., Proc Natl Acad Sci U S A 92(18), 1995
PMID: 7667276

54 References

Data provided by Europe PubMed Central.

Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.
Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R., EMBO J. 13(20), 1994
PMID: 7957052
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.
Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A., Cell 76(2), 1994
PMID: 8293468
Nuclear dot antigens may specify transcriptional domains in the nucleus.
Xie K, Lambie EJ, Snyder M., Mol. Cell. Biol. 13(10), 1993
PMID: 8413218
Localization of pre-mRNA splicing in mammalian nuclei.
Zhang G, Taneja KL, Singer RH, Green MR., Nature 372(6508), 1994
PMID: 7997273

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 7540613
PubMed | Europe PMC

Search this title in

Google Scholar